(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride CAS: 1701403-10-2
![BK207H | 1701403-10-2 | (R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride](https://qncdn.chemcd.cn/alchemypharm/AP10092.png "BK207H | 1701403-10-2 | (R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride")
| Product Parameters | |
|---|---|
| Catalog No. | BK207H |
| CAS.RN | 1701403-10-2 |
| Molecular Formula | C22H24Cl2N6O |
| Molecular Weight | 459.37 g/mol |
| Purity | NLT 98% |
Product Overview
This product is a key intermediate for ibrutinib, with the chemical name (R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride. It is widely used in the synthesis process of the antitumor drug ibrutinib and is suitable for drug development, small-scale preparation, pilot-scale amplification and commercial production stages. It has good reactivity and structural stability and is one of the important raw materials in the field of pharmaceutical intermediates.
Applications
- For the preparation of key intermediates in the ibrutinib synthetic route
- Suitable for the construction of core fragments in the anti-tumor drug development process
- Supports drug process development and route optimization research
- For customized synthesis services of pharmaceutical intermediates
- Suitable for drug molecule structure modification and functionalization research
Quality & Supply Capability
English Name: (R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride Properties: This compound is a white to off-white solid with a stable pyrazolopyrimidine structure and piperidine group. It is readily soluble in organic solvents, exhibits good thermal stability, and is suitable for various organic synthesis reactions. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the specific COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging Documentation Support: COA, MSDS, HPLC, NMR, etc. We provide a full-chain supply service from laboratory samples to industrial batches, covering small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust purity standards, impurity control requirements, packaging specifications, and delivery cycles according to customer needs, and provide a complete quality documentation system. We also provide full-process technical support from R&D to scale-up, helping customers achieve process optimization and project transformation.
Why Choose Bioncan
Focused on pharmaceutical intermediates, possessing extensive synthesis experience and technological expertise. Full-scale supply capability to meet diverse needs from laboratory to commercial production. Provides complete quality control documentation to ensure product quality compliance and controllability. Customized synthesis and process optimization can be performed according to customer requirements. Comprehensive scale-up technical support to ensure smooth process transition and stable production.
Intermediates of Ibrutinib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA374M | Ibrutinib API | 936563-96-1 |
| BK207H | (R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride | 1701403-10-2 |
| BK88V8 | 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine | 330786-24-8 |
| BK69T8 | (S)-1-Boc-3-hydroxypiperidine | 143900-44-1 |
| BK428X | (R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | 1022150-12-4 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 1701403-10-2, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.
